MiNA Therapeutics Receives $15M Equity Investment from Eli Lilly and Company

14 Jul, 2021

MiNA Therapeutics Receives $15M Equity Investment from Eli Lilly and Company
Photo by Chantal Garnier on Unsplash

– MiNA Therapeutics Limited is a London, UK-based provider of small activating RNA therapeutics.
– Company received $15m equity investment from Eli Lilly and Company.
– The funds will be used to advance and expand its internal pipeline of saRNA therapeutics.

Biotechnology Genetics Life Science Pharmaceutical Western Europe
Crunchbase icon

Content report

The following text will be sent to our editors: